About this trial
This trial studies how well low-dose postoperative corticosteroids (FDA approved) affect patient outcomes (patient reported outcomes, pain medication use, length of stay, major complications, and time to first bowel movement) after thoracic and/or lumbar spine fusion surgery.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
All patients over the age of 50 undergoing thoracic and/or lumbar fusion with a Spine Center surgeon will be included
Disqualifiers
Patient is already taking chronic steroids
Patient is pregnant
Patient is decisionally impaired
Patient is a prisoner
Trial design
Parallel
Treatments tested in this trial
Prednisone 20 Mg
Drug20 mg of Prednisone or 1 mL of 4 mg/mL Dexamethasone Sodium Phosphate will be administered each day for participants in the intervention group
Treatment groups
Trial outcomes
Primary outcomes
Morphine equivalent pain medication use over the length of hospitalization
This will be measured by converting the dosage of the pain medication administered to its equivalent dosage of morphine.
Length of hospital stay after surgery
This will be measured by taking the total minutes the patient stays in the hospital after surgery from time of admission to time of discharge.
Time to first bowel movement in hospital after surgery
This will be measured in the total number of minutes from admission after surgery that it takes for the patient to have their first bowel movement recorded.
Number of major complications reported during hospital stay after surgery
This will be measured in the total number of major complications (any) that occur during the hospital stay after surgery. These include, infection, neurological deficit, myocardial infarction, stroke, pneumonia, pulmonary embolism, and bleeding.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: